Laurion Capital Management LP Cardiff Oncology, Inc. Transaction History
Laurion Capital Management LP
- $11.4 Billion
- Q1 2024
A detailed history of Laurion Capital Management LP transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 928,717 shares of CRDF stock, worth $2.06 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
928,717
Previous 722,100
28.61%
Holding current value
$2.06 Million
Previous $1.07 Million
364.33%
% of portfolio
0.04%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CRDF
# of Institutions
86Shares Held
8.48MCall Options Held
798KPut Options Held
39.2K-
Vanguard Group Inc Valley Forge, PA1.92MShares$4.27 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny683KShares$1.52 Million0.0% of portfolio
-
Black Rock Inc. New York, NY677KShares$1.5 Million0.0% of portfolio
-
Mai Capital Management551KShares$1.22 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA435KShares$965,3290.0% of portfolio
About Cardiff Oncology, Inc.
- Ticker CRDF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,334,900
- Market Cap $96.2M
- Description
- Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...